Cytiva

  • 210203_CK_Cytiva_05_Results_Way_3414-2 _3_
    Article

    Large-scale AAV manufacturing for non-rare diseases

    2026-10-19T10:02:00Sponsored by

    As AAV therapies move beyond rare disease indications, manufacturing scalability becomes critical. Learn how an integrated approach to process development can help reduce risk, improve yields, and prepare for commercial success.